Long-Term glycemic control and the risk of liver stiffness progression and liver-related events in MASLD
Long-Term glycemic control and the risk of liver stiffness progression and liver-related events in MASLD
Background & Aims: the long-term impact of type 2 diabetes (T2D) status and long-term glycemic control on disease progression and clinical outcomes in metabolic dysfunction–associated steatotic liver disease (MASLD) remains unclear. The study sought to assess the association of diabetes status and long-term glycemic control with liver stiffness progression or regression, and liver-related events (LREs) in MASLD.
Methods: we analyzed patients with MASLD from the VCTE-Prognosis cohort who underwent serial vibration-controlled transient elastography (VCTE) assessments and hemoglobin A1c (HbA1c) measurements. Long-term glycemic control was evaluated using the time-weighted average (TWA) HbA1c, which reflects both the magnitude and duration of glycemia. Patients were categorized as non-T2D, well-controlled T2D (TWA HbA1c<7%), or poorly controlled T2D (TWA HbA1c ≥7%). Liver stiffness progression, regression, and LREs were examined using Kaplan-Meier analyses and Cox proportional hazards models.
Results: of 7543 patients with MASLD, 4090 had T2D (2045 well controlled, 2045 poorly controlled) and 3453 did not have T2D. Over a median follow-up of 4.1 years, patients with T2D had a higher risk of liver stiffness progression (hazard ratio [HR], 1.501, 95% confidence interval [CI]. 1.148–1.962; P = .003) and LREs (HR, 2.030; 95% CI, 1.241–3.320; P = .005), but not liver stiffness regression, compared with non-T2D patients. Among patients with T2D, poor glycemic control was associated with a higher risk of liver stiffness progression compared with good glycemic control (HR, 1.524; 95% CI, 1.182–1.965; P = .001). No differences were observed for liver stiffness regression (P = .957) or LREs (P = .625) with glycemic control. Findings were consistent across sensitivity analyses.
Conclusions: T2D was independently associated with a higher risk of liver stiffness progression and LREs in MASLD. Good glycemic control was associated with slower liver stiffness progression, but not regression or LREs.
Zhou, Xiao-Dong
686b3c00-3307-4499-a367-530c0543a78c
Chen, Qin-Fen
75e0ec4c-ac2f-465b-a48a-292a28ef823a
Kim, Seung Up
41fe5f6d-682f-4e90-86a6-83ed5fbbbb93
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
4 November 2025
Zhou, Xiao-Dong
686b3c00-3307-4499-a367-530c0543a78c
Chen, Qin-Fen
75e0ec4c-ac2f-465b-a48a-292a28ef823a
Kim, Seung Up
41fe5f6d-682f-4e90-86a6-83ed5fbbbb93
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Zhou, Xiao-Dong, Chen, Qin-Fen and Kim, Seung Up
,
et al.
(2025)
Long-Term glycemic control and the risk of liver stiffness progression and liver-related events in MASLD.
Clinical Gastroenterology and Hepatology.
(doi:10.1016/j.cgh.2025.10.003).
Abstract
Background & Aims: the long-term impact of type 2 diabetes (T2D) status and long-term glycemic control on disease progression and clinical outcomes in metabolic dysfunction–associated steatotic liver disease (MASLD) remains unclear. The study sought to assess the association of diabetes status and long-term glycemic control with liver stiffness progression or regression, and liver-related events (LREs) in MASLD.
Methods: we analyzed patients with MASLD from the VCTE-Prognosis cohort who underwent serial vibration-controlled transient elastography (VCTE) assessments and hemoglobin A1c (HbA1c) measurements. Long-term glycemic control was evaluated using the time-weighted average (TWA) HbA1c, which reflects both the magnitude and duration of glycemia. Patients were categorized as non-T2D, well-controlled T2D (TWA HbA1c<7%), or poorly controlled T2D (TWA HbA1c ≥7%). Liver stiffness progression, regression, and LREs were examined using Kaplan-Meier analyses and Cox proportional hazards models.
Results: of 7543 patients with MASLD, 4090 had T2D (2045 well controlled, 2045 poorly controlled) and 3453 did not have T2D. Over a median follow-up of 4.1 years, patients with T2D had a higher risk of liver stiffness progression (hazard ratio [HR], 1.501, 95% confidence interval [CI]. 1.148–1.962; P = .003) and LREs (HR, 2.030; 95% CI, 1.241–3.320; P = .005), but not liver stiffness regression, compared with non-T2D patients. Among patients with T2D, poor glycemic control was associated with a higher risk of liver stiffness progression compared with good glycemic control (HR, 1.524; 95% CI, 1.182–1.965; P = .001). No differences were observed for liver stiffness regression (P = .957) or LREs (P = .625) with glycemic control. Findings were consistent across sensitivity analyses.
Conclusions: T2D was independently associated with a higher risk of liver stiffness progression and LREs in MASLD. Good glycemic control was associated with slower liver stiffness progression, but not regression or LREs.
Text
Revised Manuscript (no changes marked)
- Accepted Manuscript
Restricted to Repository staff only until 1 October 2026.
Request a copy
Text
Supplementary materials
- Accepted Manuscript
Restricted to Repository staff only until 1 October 2026.
Request a copy
Text
Tables
- Accepted Manuscript
Restricted to Repository staff only until 1 October 2026.
Request a copy
Text
What You Need to Know
- Accepted Manuscript
Restricted to Repository staff only until 1 October 2026.
Request a copy
Slideshow
cgh-graphical-abstract
- Accepted Manuscript
Restricted to Repository staff only until 1 October 2026.
Request a copy
Text
Figures
- Accepted Manuscript
Restricted to Repository staff only until 1 October 2026.
Request a copy
Show all 6 downloads.
More information
Accepted/In Press date: 1 October 2025
e-pub ahead of print date: 9 October 2025
Published date: 4 November 2025
Identifiers
Local EPrints ID: 506731
URI: http://eprints.soton.ac.uk/id/eprint/506731
ISSN: 1542-3565
PURE UUID: 13db942e-3913-49cf-b1c7-a50f9911b0f5
Catalogue record
Date deposited: 17 Nov 2025 17:47
Last modified: 18 Nov 2025 02:36
Export record
Altmetrics
Contributors
Author:
Xiao-Dong Zhou
Author:
Qin-Fen Chen
Author:
Seung Up Kim
Corporate Author: et al.
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics